- Home
- STXS vs NKTR Comparison
STXS vs NKTR Comparison
Compare STXS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STXS
- NKTR
- Stock Information
- Founded
- STXS 1990
- NKTR 1990
- Country
- STXS United States
- NKTR United States
- Employees
- STXS N/A
- NKTR N/A
- Industry
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- STXS Health Care
- NKTR Health Care
- Exchange
- STXS Nasdaq
- NKTR Nasdaq
- Market Cap
- STXS 151.3M
- NKTR 125.5M
- IPO Year
- STXS 2004
- NKTR 1994
- Fundamental
- Price
- STXS $2.13
- NKTR $8.51
- Analyst Decision
- STXS
- NKTR Strong Buy
- Analyst Count
- STXS 0
- NKTR 6
- Target Price
- STXS N/A
- NKTR $73.75
- AVG Volume (30 Days)
- STXS 207.9K
- NKTR 348.5K
- Earning Date
- STXS 08-11-2025
- NKTR 08-07-2025
- Dividend Yield
- STXS N/A
- NKTR N/A
- EPS Growth
- STXS N/A
- NKTR N/A
- EPS
- STXS N/A
- NKTR N/A
- Revenue
- STXS $27,510,000.00
- NKTR $87,248,000.00
- Revenue This Year
- STXS $25.90
- NKTR N/A
- Revenue Next Year
- STXS $60.57
- NKTR N/A
- P/E Ratio
- STXS N/A
- NKTR N/A
- Revenue Growth
- STXS 1.50
- NKTR N/A
- 52 Week Low
- STXS $1.54
- NKTR $6.48
- 52 Week High
- STXS $2.72
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- STXS 47.58
- NKTR 42.19
- Support Level
- STXS $2.06
- NKTR $7.99
- Resistance Level
- STXS $2.36
- NKTR $9.71
- Average True Range (ATR)
- STXS 0.11
- NKTR 1.37
- MACD
- STXS -0.01
- NKTR -0.20
- Stochastic Oscillator
- STXS 19.70
- NKTR 11.66
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.